A Phase 1b Study of Crizotinib in Combination with Temsirolimus in Pediatric ALK- or MET-aberrated Relapsed or Refractory Neuroblastoma (ITCC-053): Results of the Phase 1 PartKim Schellekens,Reineke Anna Schoot,Natasha K. A. van Eijkelenburg,Alwin Huitema,Michela Casanova,Dirk Reinhardt,Lynley V. Marshall,Isabelle Aerts,Giuseppe Barone,Louis Chesler, Jennifer Tall,Debbie Hughes,Rana Dandis,Lucas Moreno, Pauline L. H. Winkler-Seinstra,Keith D. Wilner,C. Michel Zwaan,Jasper van der LugtJOURNAL OF CLINICAL ONCOLOGY（2023）引用 0|浏览28暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
